PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Colonic metastasis from breast carcinoma detection by CESM and PET/CT: A case report.

Abstract Metastatic spread in invasive lobular carcinoma (ILC) of breast mainly occurs in bones, gynecological organs, peritoneum, retroperitoneum, and gastrointestinal (GI) tract. Metastases to the GI tract may arise many years after initial diagnosis and can affect the tract from the tongue to the anus, stomach being the most commonly involved site. Clinical presentations are predominantly nonspecific, and rarely asymptomatic. CEA, CA 15-3, and CA 19-9 may be informative for symptomatic patients who have had a previous history of breast cancer.
PMID
Related Publications

Role of 2-18F fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.

Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.

Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?

Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.

Colonic metastasis from breast carcinoma: a case report.

Authors

Mayor MeshTerms
Keywords
Journal Title medicine
Publication Year Start




PMID- 29794798
OWN - NLM
STAT- MEDLINE
DCOM- 20180604
LR  - 20180604
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 97
IP  - 21
DP  - 2018 May
TI  - Colonic metastasis from breast carcinoma detection by CESM and PET/CT: A case
      report.
PG  - e10888
LID - 10.1097/MD.0000000000010888 [doi]
AB  - INTRODUCTION: Metastatic spread in invasive lobular carcinoma (ILC) of breast
      mainly occurs in bones, gynecological organs, peritoneum, retroperitoneum, and
      gastrointestinal (GI) tract. Metastases to the GI tract may arise many years
      after initial diagnosis and can affect the tract from the tongue to the anus,
      stomach being the most commonly involved site. Clinical presentations are
      predominantly nonspecific, and rarely asymptomatic. CEA, CA 15-3, and CA 19-9 may
      be informative for symptomatic patients who have had a previous history of breast
      cancer. CASE PRESENTATION: We introduce the case of asymptomatic colonic
      metastasis from breast carcinoma in a 67-year-old woman followed-up for Luminal A
      ILC. Diagnosis was performed through positron emission tomography/computed
      tomography (PET/CT) scan and contrast-enhancement spectral mammography (CESM),
      steering endoscopist to spot the involved intestinal tract and in ruling out
      further dissemination in the breast parenchyma. CONCLUSION: In colonic
      metastases, tumor markers might not be totally reliable. In asymptomatic cases,
      clinical conditions might be underappreciated, missing local or distant
      recurrence. CT and PET/CT scan might be useful in diagnosing small volume
      diseases, and steering endoscopist toward GI metastasis originating from the
      breast. CESM represents a tolerable and feasible tool that rules out
      multicentricity and multifocality of breast localization. Moreover, particular
      patients could tolerate it better than magnetic resonance imaging (MRI).
FAU - Falco, Giuseppe
AU  - Falco G
AD  - Department of Oncology and Advanced Technologies, Breast Surgery Unit, IRCSS
      Santa Maria Nuova Hospital, Reggio Emilia.
FAU - Mele, Simone
AU  - Mele S
AD  - Department of Oncology and Advanced Technologies, Breast Surgery Unit, IRCSS
      Santa Maria Nuova Hospital, Reggio Emilia.
FAU - Zizzo, Maurizio
AU  - Zizzo M
AD  - Department of Oncology and Advanced Technologies, Surgical Oncology Unit, IRCCS
      Santa Maria Nuova Hospital, Reggio Emilia.
AD  - Clinical and Experimental Medicine PhD Program, University of Modena and Reggio
      Emilia, Modena.
FAU - Di Grezia, Graziella
AU  - Di Grezia G
AD  - Radiology Department, Criscuoli Hospital, Sant' Angelo dei Lombardi, Avellino.
FAU - Cecinato, Paolo
AU  - Cecinato P
AD  - Department of Oncology and Advanced Technologies, Gastroenterology-Digestive
      Endoscopy Unit, IRCCS Santa Maria Nuova Hospital, Reggio Emilia.
FAU - Besutti, Giulia
AU  - Besutti G
AD  - Clinical and Experimental Medicine PhD Program, University of Modena and Reggio
      Emilia, Modena.
AD  - Department of Imaging and Medicine of Laboratory, Radiology Unit, IRCCS Santa
      Maria Nuova Hospital, Reggio Emilia.
FAU - Coiro, Saverio
AU  - Coiro S
AD  - Department of Oncology and Advanced Technologies, Breast Surgery Unit, IRCSS
      Santa Maria Nuova Hospital, Reggio Emilia.
FAU - Gatta, Gianluca
AU  - Gatta G
AD  - Radiology Department, "Luigi Vanvitelli" University of Campania, Naples, Italy.
FAU - Vacondio, Rita
AU  - Vacondio R
AD  - Department of Imaging and Medicine of Laboratory, Radiology Unit, IRCCS Santa
      Maria Nuova Hospital, Reggio Emilia.
FAU - Ferrari, Guglielmo
AU  - Ferrari G
AD  - Department of Oncology and Advanced Technologies, Breast Surgery Unit, IRCSS
      Santa Maria Nuova Hospital, Reggio Emilia.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
RN  - 0 (Mucin-1)
RN  - 0 (Receptors, Cell Surface)
RN  - 0 (carcinoembryonic antigen binding protein, human)
RN  - 0Z5B2CJX4D (Fluorodeoxyglucose F18)
SB  - AIM
SB  - IM
MH  - Aged
MH  - Asymptomatic Diseases/epidemiology
MH  - Breast/*pathology
MH  - Breast Neoplasms/*pathology
MH  - Carcinoma, Lobular/*diagnostic imaging/metabolism/pathology
MH  - Colectomy/methods
MH  - Colon/*pathology
MH  - Colonic Neoplasms/diagnostic imaging/pathology/*secondary/surgery
MH  - Colonoscopy/methods
MH  - Female
MH  - Fluorodeoxyglucose F18/metabolism
MH  - Humans
MH  - Mammography/methods
MH  - Mucin-1/metabolism
MH  - Neoplasm Invasiveness/pathology
MH  - Neoplasm Metastasis/*diagnostic imaging/pathology
MH  - Positron Emission Tomography Computed Tomography/methods
MH  - Receptors, Cell Surface/metabolism
MH  - Treatment Outcome
EDAT- 2018/05/26 06:00
MHDA- 2018/06/05 06:00
CRDT- 2018/05/26 06:00
PHST- 2018/05/26 06:00 [entrez]
PHST- 2018/05/26 06:00 [pubmed]
PHST- 2018/06/05 06:00 [medline]
AID - 10.1097/MD.0000000000010888 [doi]
AID - 00005792-201805250-00074 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2018 May;97(21):e10888. doi: 10.1097/MD.0000000000010888.